Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $688.39 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $215.99 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $165.05 | 2 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $141.51 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $123.35 | 1 | $0 (2021) |
| PORTOLA PHARMACEUTICALS, INC. | $26.58 | 1 | $0 (2018) |
| Medical Device Business Services, Inc. | $15.91 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $196.30 | 2 | Myriad Genetic Laboratories, Inc. ($141.51) |
| 2021 | $123.35 | 1 | GlaxoSmithKline, LLC. ($123.35) |
| 2019 | $215.99 | 2 | TESARO, Inc. ($215.99) |
| 2018 | $152.75 | 3 | AstraZeneca Pharmaceuticals LP ($110.26) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/27/2023 | Myriad Genetic Laboratories, Inc. | PRECISETUMOR (Device) | Food and Beverage | In-kind items and services | $141.51 | General |
| Category: ONCOLOGY | ||||||
| 03/25/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $54.79 | General |
| Category: Oncology | ||||||
| 06/01/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $123.35 | General |
| Category: ONCOLOGY | ||||||
| 07/19/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $91.00 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $110.26 | General |
| Category: Oncology | ||||||
| 04/12/2018 | Medical Device Business Services, Inc. | HARMONIC Product Family (Device) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Energy | ||||||
| 03/07/2018 | PORTOLA PHARMACEUTICALS, INC. | BEVYXXA (Drug) | Food and Beverage | Cash or cash equivalent | $26.58 | General |
| Category: CARDIOLOGY/HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 60 | 96 | $30,090 | $6,357 |
| 2022 | 3 | 44 | 45 | $13,845 | $4,394 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 47 | $14,100 | $2,727 | 19.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $6,540 | $1,540 | 23.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 14 | $4,620 | $1,207 | 26.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 14 | 23 | $4,830 | $883.65 | 18.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 16 | $5,760 | $1,792 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 17 | $4,845 | $1,644 | 33.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $3,240 | $957.45 | 29.6% |
About Dr. Mary Mullen, MD
Dr. Mary Mullen, MD is a Gynecologic Oncology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2014. The National Provider Identifier (NPI) number assigned to this provider is 1437563897.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Mullen, MD has received a total of $688.39 in payments from pharmaceutical and medical device companies, with $196.30 received in 2023. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($688.39).
As a Medicare-enrolled provider, Mullen has provided services to 104 Medicare beneficiaries, totaling 141 services with total Medicare billing of $10,751. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Gynecologic Oncology
- Location Saint Louis, MO
- Active Since 06/13/2014
- Last Updated 04/17/2025
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1437563897
Products in Payments
- ZEJULA (Drug) $339.34
- LYNPARZA (Drug) $165.05
- PRECISETUMOR (Device) $141.51
- BEVYXXA (Drug) $26.58
- HARMONIC Product Family (Device) $15.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Saint Louis
Dr. Matthew Powell, Md, MD
Gynecologic Oncology — Payments: $371,500
Dr. Premal Thaker, Md, MD
Gynecologic Oncology — Payments: $343,223
Dr. David Mutch, Md, MD
Gynecologic Oncology — Payments: $89,524
Dr. Carolyn Mccourt, Md, MD
Gynecologic Oncology — Payments: $34,327
Dan-Arin Silasi, Md, MD
Gynecologic Oncology — Payments: $27,564
Dr. Dineo Khabele, Md, MD
Gynecologic Oncology — Payments: $21,978